These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 32271688)

  • 21. Risky communication: pitfalls in counseling about risk, and how to avoid them.
    O'Doherty K; Suthers GK
    J Genet Couns; 2007 Aug; 16(4):409-17. PubMed ID: 17473963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and pilot testing of a decision aid for men considering genetic testing for breast and/or ovarian cancer-related mutations (BRCA1/2).
    Juan AS; Wakefield CE; Kasparian NA; Kirk J; Tyler J; Tucker K
    Genet Test; 2008 Dec; 12(4):523-32. PubMed ID: 19072564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Statement of the American Society of Human Genetics on genetic testing for breast and ovarian cancer predisposition.
    Am J Hum Genet; 1994 Nov; 55(5):i-iv. PubMed ID: 7977337
    [No Abstract]   [Full Text] [Related]  

  • 24. Talking across generations: Family communication about BRCA1 and BRCA2 genetic cancer risk.
    Young AL; Butow PN; Rhodes P; Tucker KM; Williams R; Healey E; Wakefield CE
    J Genet Couns; 2019 Jun; 28(3):516-532. PubMed ID: 30694012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physicians communicating with women at genetic risk of breast and ovarian cancer: Are we in the middle of the ford between contradictory messages and unshared decision making?
    Fadda M; Chappuis PO; Katapodi MC; Pagani O; Monnerat C; Membrez V; Unger S; Caiata Zufferey M
    PLoS One; 2020; 15(10):e0240054. PubMed ID: 33031463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Nelson HD; Pappas M; Cantor A; Haney E; Holmes R
    JAMA; 2019 Aug; 322(7):666-685. PubMed ID: 31429902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Communicating with Daughters About Familial Risk of Breast Cancer: Individual, Family, and Provider Influences on Women's Knowledge of Cancer Risk.
    Peipins LA; Rodriguez JL; Hawkins NA; Soman A; White MC; Hodgson ME; DeRoo LA; Sandler DP
    J Womens Health (Larchmt); 2018 May; 27(5):630-639. PubMed ID: 29377785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maternal perceptions of BRCA genetic counseling communication processes about disclosing cancer risk information to children and adult relatives.
    Hamilton JG; Peshkin BN; Mays D; DeMarco TA; Patenaude AF; Tercyak KP
    Psychooncology; 2018 Jul; 27(7):1825-1832. PubMed ID: 29645321
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic susceptibility testing. A therapeutic illusion.
    Freedman TG
    Cancer; 1997 Jun; 79(11):2063-5; discussion 2066. PubMed ID: 9179051
    [No Abstract]   [Full Text] [Related]  

  • 30. Genetic counseling does not fulfill the counselees' need for certainty in hereditary breast/ovarian cancer families: an explorative assessment.
    Vos J; Menko FH; Oosterwijk JC; van Asperen CJ; Stiggelbout AM; Tibben A
    Psychooncology; 2013 May; 22(5):1167-76. PubMed ID: 22777929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk in numbers--difficulties in the transformation of genetic knowledge from research to people--the case of hereditary cancer.
    Sachs L; Taube A; Tishelman C
    Acta Oncol; 2001; 40(4):445-53. PubMed ID: 11504302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Women's experiences of undergoing BRCA1 and BRCA2 testing: organisation of the German Hereditary Breast and Ovarian Cancer Consortium Survey and Preliminary Data from Münster.
    Nippert I; Schlegelberger B;
    Community Genet; 2003; 6(4):249-58. PubMed ID: 15331871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized trial of a breast/ovarian cancer genetic testing decision aid used as a communication aid during genetic counseling.
    Wakefield CE; Meiser B; Homewood J; Taylor A; Gleeson M; Williams R; Tucker K;
    Psychooncology; 2008 Aug; 17(8):844-54. PubMed ID: 18613319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A current perspective on genetic testing for breast and ovarian cancer: the oral contraceptive decision.
    Friedenson B
    MedGenMed; 2001 Nov; 3(6):2. PubMed ID: 11965197
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modeling the dyadic effects of parenting, stress, and coping on parent-child communication in families tested for hereditary breast-ovarian cancer risk.
    Hamilton JG; Mays D; DeMarco T; Tercyak KP
    Fam Cancer; 2016 Oct; 15(4):513-22. PubMed ID: 26848859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The communication of uncertainty in health: A scoping review.
    Kalke K; Studd H; Scherr CL
    Patient Educ Couns; 2021 Aug; 104(8):1945-1961. PubMed ID: 33593644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BRCA mutation-negative women from hereditary breast and ovarian cancer families: a qualitative study of the BRCA-negative experience.
    Bakos AD; Hutson SP; Loud JT; Peters JA; Giusti RM; Greene MH
    Health Expect; 2008 Sep; 11(3):220-31. PubMed ID: 18816319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk communication strategies: state of the art and effectiveness in the context of cancer genetic services.
    Julian-Reynier C; Welkenhuysen M; Hagoel L; Decruyenaere M; Hopwood P;
    Eur J Hum Genet; 2003 Oct; 11(10):725-36. PubMed ID: 14512961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Communication about genetic testing in families of male BRCA1/2 carriers and non-carriers: patterns, priorities and problems.
    Hallowell N; Ardern-Jones A; Eeles R; Foster C; Lucassen A; Moynihan C; Watson M
    Clin Genet; 2005 Jun; 67(6):492-502. PubMed ID: 15857416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Attitudes toward genetic testing for cancer risk after genetic counseling and decision support: a qualitative comparison between hereditary cancer types.
    Wakefield CE; Kasparian NA; Meiser B; Homewood J; Kirk J; Tucker K
    Genet Test; 2007; 11(4):401-11. PubMed ID: 18294057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.